Espinoza Octavio — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Espinoza Octavio has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $4.04M.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-06LGNDLIGAND PHARMACEUTICALS INCJ — Other acquisition / disposition17$160.71$3K
2026-05-28LGNDLIGAND PHARMACEUTICALS INCM — Option exercise972$52.84$51K
2026-05-28LGNDLIGAND PHARMACEUTICALS INCM — Option exercise764$63.62$49K
2026-03-28LGNDLIGAND PHARMACEUTICALS INCA — Grant or award4.9K$0.00
2026-03-13LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]3.1K$225.00$688K
2026-03-13LGNDLIGAND PHARMACEUTICALS INCM — Option exercise [10b5-1]2.4K$92.65$223K
2026-03-06LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]3.4K$208.80$713K
2026-03-06LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]2.5K$207.91$511K
2026-03-06LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]1.6K$206.89$329K
2026-03-06LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]1.5K$205.79$300K
2026-03-06LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]743$204.74$152K
2026-03-06LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]668$203.63$136K
2026-03-06LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]697$202.79$141K
2026-03-06LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]950$201.73$192K
2026-03-06LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]698$201.09$140K
2026-03-06LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]53$200.08$11K
2026-03-06LGNDLIGAND PHARMACEUTICALS INCS — Open-market sale [10b5-1]699$198.71$139K
2026-03-06LGNDLIGAND PHARMACEUTICALS INCM — Option exercise [10b5-1]466$80.72$38K
2026-03-06LGNDLIGAND PHARMACEUTICALS INCM — Option exercise [10b5-1]1.6K$58.49$94K
2026-02-18LGNDLIGAND PHARMACEUTICALS INCF — Tax withholding / forfeiture1.3K$183.83$233K

Companies — Last 90 Days

Frequently Asked Questions

Who is Espinoza Octavio?

Espinoza Octavio is a corporate insider — currently tracked as Chief Financial Officer of LIGAND PHARMACEUTICALS INC (LGND). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has Espinoza Octavio submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has Espinoza Octavio been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 14 open-market sales ($4.04M) across all tracked filings.

Where can I see all of Espinoza Octavio's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Espinoza Octavio profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.